Technical Articles

A selection guide for recombinant human Nectin-3/CD113 His Tag protein: reading SPR and ELISA interaction data, tag and capture considerations for binding studies, and arrival acceptance criteria.

Nectin-3 (CD113/PVRL3) is an immunoglobulin-like adhesion molecule of the nectin family. This article covers its binding partners, SPR and ELISA-based activity validation, and experimental uses of recombinant human Nectin-3.

A selection guide for recombinant human Cyclin A2: why the E174-L432 fragment matters, reading SDS-PAGE and SEC-HPLC data, and arrival acceptance criteria for CDK2-binding and kinase assays.

Cyclin A2 is the core S-phase and M-phase cyclin that activates CDK2 and CDC2. This article explains its expression timing, the E174-L432 construct boundary and how recombinant Cyclin A2 supports kinase and complex-reconstitution studies.

This article traces RNase inhibitor from a routine lab additive to a quality-critical component in mRNA production: IVT and capping steps, batch consistency, and why reagent standardization matters for RNA therapeutics manufacturing.

A practical troubleshooting guide for RNA work: where RNase contamination hides, when adding RNase inhibitor helps and when it cannot, DTT dependence and the checkout sequence for intact-RNA experiments.

RNase inhibitor is a 50 kDa leucine-rich repeat protein that binds RNase A family enzymes with femtomolar affinity. This article explains its inhibition mechanism, redox sensitivity and species origin considerations.

This article focuses on the molecular characteristics and biological functions of Annexin V, systematically elaborating its core mechanism as a calcium-dependent phospholipid-binding protein that detects apoptosis by recognizing phosphatidylserine exposure, analyzing the key operational points and common troubleshooting in apoptosis detection experiments using Annexin V, and discussing its clinical translation prospects from basic apoptosis detection to targeted drug delivery, neuroprotection, and cardiovascular disease treatment.

A selection guide for recombinant CNTF: species matching, bioactivity data interpretation, purity considerations and acceptance criteria for reproducible neuronal culture and neuroprotection studies.

CNTF is an IL-6 family neurotrophic cytokine acting through CNTFR/gp130/LIFR. This article covers its neuroprotective mechanisms, retinal ganglion cell evidence and activity determination with recombinant rat CNTF.